4.7 Article

Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Overexpression of Interleukin-33 in Recombinant Rabies Virus Enhances Innate and Humoral Immune Responses through Activation of Dendritic Cell-Germinal Center Reactions

Zhizhong Mi et al.

Summary: This study constructed a recombinant rabies vaccine rLBNSE-IL33 and evaluated its effect in a mouse model. The results showed that rLBNSE-IL33 could enhance the production of immune antibodies and provide better protection against rabies by activating dendritic cells and regulating the germinal center reaction.

VACCINES (2022)

Article

Rabies Infection: An Overview of Lyssavirus-Host Protein Interactions

Fatemeh Zandi et al.

Iranian Biomedical Journal (2021)

Article Biochemistry & Molecular Biology

Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage

Kun Wang et al.

Summary: Compound 8a showed broad-spectrum anti-coronavirus effects by potentially inhibiting host cathepsin B activity to block the late stage of viral entry. Additionally, it could reduce the release of multiple inflammatory cytokines, contributing to the suppression of cytokine storm.

BIOORGANIC CHEMISTRY (2021)

Article Chemistry, Medicinal

Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo

Alexey Koval et al.

Summary: Clofazimine has been optimized to enhance its potency as a Wnt inhibitor, with MU17 identified as a more potent lead compound for targeted therapy against TNBC and Wnt-dependent cancers. MU17 displayed a 7-fold improved potency against Wnt signaling in TNBC cells and showed no adverse effects, particularly no clofazimine-related skin coloration.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

Shuofeng Yuan et al.

Summary: The anti-leprosy drug clofazimine has shown inhibitory activity against various coronaviruses, reducing viral loads in the lung and shedding, as well as alleviating inflammation. Combination with remdesivir exhibited antiviral synergy, suggesting potential for treating COVID-19 patients, particularly in resource-limited settings.

NATURE (2021)

Article Pharmacology & Pharmacy

Clofazimine: A Promising Inhibitor of Rabies Virus

Jiajing Wu et al.

Summary: Research identified clofazimine (CFZ) as an effective drug against rabies virus, targeting viral membrane fusion to interfere with virus replication. CFZ exhibited higher survival rates compared to the positive control in experiments.

FRONTIERS IN PHARMACOLOGY (2021)

Article Immunology

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Jianhui Nie et al.

EMERGING MICROBES & INFECTIONS (2020)

Article Immunology

A social justice perspective on access to human rabies vaccines

Diorbhail Wentworth et al.

VACCINE (2019)

Article Chemistry, Medicinal

Novel Hydrophilic Riminophenazines as Potent Antiprotozoal Agents

Ivan Bassanini et al.

CHEMMEDCHEM (2019)

Article Dermatology

The Physicochemical Basis of Clofazimine-Induced Skin Pigmentation

Mikhail D. Murashov et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)

Article Chemistry, Medicinal

Identification of Less Lipophilic Riminophenazine Derivatives for the Treatment of Drug-Resistant Tuberculosis

Dongfeng Zhang et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Review Microbiology

The cell biology of rabies virus: using stealth to reach the brain

Matthias J. Schnell et al.

NATURE REVIEWS MICROBIOLOGY (2010)

Article Infectious Diseases

Update on rabies diagnosis and treatment

Alan C. Jackson

Current Infectious Disease Reports (2009)

Review Medicine, General & Internal

Overview, prevention, and treatment of rabies

DG Hankins et al.

MAYO CLINIC PROCEEDINGS (2004)